Corrigendum: Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.

Autor:	Brito, Victor Gustavo Balera, Patrocinio, Mariana Sousa, Linjardi, Maria Carolina, Emanuelli Alves Barreto, Ayná, Frasnelli, Sabrina CT, Lara, Vanessa, Santos, Carlos Ferreira, Oliveira, Sandra Helena Penha
Předmět:	RAT diseases PERIODONTAL disease HYPERTENSION OSTEOCLASTOGENESIS BONES BONE metabolism
Zdroj:	Frontiers in Pharmacology; 2/19/2021, Vol. 11, pN.PAG-N.PAG, 1p
Abstrakt:	Keywords: telmisartan; AT1 blocker; bone metabolism; spontaneous hypertensive rats; periodontal disease; osteoblast; osteoclast; cytokines EN telmisartan AT1 blocker bone metabolism spontaneous hypertensive rats periodontal disease osteoblast osteoclast cytokines N.PAG N.PAG 1 02/24/21 20210219 NES 210219 In the original article, there was a mistake in Figure 3 as published. Telmisartan, AT1 blocker, bone metabolism, spontaneous hypertensive rats, periodontal disease, osteoblast, osteoclast, cytokines. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu